Research programme: artificial platelets - Advanced TherapeuticsAlternative Names: Artificial platelets-ADVTX; Fibrinoplate-S
Latest Information Update: 16 Jul 2016
At a glance
- Originator Advanced Therapeutics & Co
- Mechanism of Action Blood coagulation factor modulators
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- Available For Licensing Yes
Highest Development Phases
- No development reported Thrombocytopenia
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Thrombocytopenia in USA (IV, Injection)
- 16 Jul 2016 No recent reports of development identified for preclinical development in Thrombocytopenia in China (IV, Injection)
- 15 Jul 2009 Preclinical trials in Thrombocytopenia in USA (IV)